Study of the concentration of mucoprotein in the gastric juice from healthy subjects and gastroduodenal patients before and after treatment with a gastro-protective drug, zolimidine.
D000328:Adult; D000368:Aged; D004381:Duodenal Ulcer / Q000188:drug therapy; D005260:Female; D005750:Gastric Juice / Q000032:analysis*; D005753:Gastric Mucosa / Q000187:drug effects; D005756:Gastritis / Q000188:drug therapy; D005765:Gastrointestinal Agents / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009088:Mucoproteins / Q000032:analysis*; D011241:Prednisone / Q000009:adverse effects; D011725:Pyridines / Q000494:pharmacology* / Q000627:therapeutic use; D013272:Stomach Diseases / Q000139:chemically induced / Q000188:drug therapy; D013276:Stomach Ulcer / Q000188:drug therapy; D013450:Sulfones / Q000494:pharmacology / Q000627:therapeutic use
D005765:Gastrointestinal Agents; D007093:Imidazoles; D009088:Mucoproteins; D011725:Pyridines; D013450:Sulfones; D011241:Prednisone